BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL

  January 21, 2026

   · 

  4 min read
• Press Releases

  Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)

  January 21, 2026

   · 

  4 min read
• Press Releases

  Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position

  January 21, 2026

   · 

  5 min read
• Press Releases

  SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247

  January 21, 2026

   · 

  6 min read
• Press Releases

  Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates

  January 21, 2026

   · 

  5 min read
• Press Releases

  Crystalys Therapeutics Expands Leadership Team with Appointment of Justin Thacker as Chief Financial Officer to Support Advancement of Phase 3 Trials of Dotinurad

  January 21, 2026

   · 

  3 min read
• Press Releases

  LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel

  January 21, 2026

   · 

  5 min read
• Press Releases

  Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology

  January 21, 2026

   · 

  3 min read
• Press Releases

  Ember LifeSciences appoints Ann Hyllengren as Chief Financial Officer

  January 21, 2026

   · 

  3 min read